Aria CV Announces First Patient Successfully Implanted with Second-Generation Pulmonary Hypertension System February 27, 2024-Aria CV
Aria Completes $31m Series B for its Pulmonary Hypertension Treatment Device February 25, 2020-Aria CV
Aria CV Receives FDA Breakthrough Designation for its Medical Device for Treating Pulmonary Arterial Hypertension February 6, 2020-Aria CV